...
首页> 外文期刊>International journal of oncology >Transforming growth factor-β-induced miR?143 expression in regulation of non-small cell lung cancer cell viability and invasion capacity in vitro and in vivo
【24h】

Transforming growth factor-β-induced miR?143 expression in regulation of non-small cell lung cancer cell viability and invasion capacity in vitro and in vivo

机译:转化生长因子-β诱导的miR?143表达在体外和体内非小细胞肺癌细胞生存能力和侵袭能力的调控中

获取原文

摘要

Altered expression of miRNAs contributes to development and progression of non-small cell lung cancer (NSCLC), while transforming growth factor-β (TGF-β) promotes NSCLC cell epithelial-mesenchymal transition. This study aimed to investigate the effects of TGF-β-induced miR?143 expression in regulation of NSCLC cell viability, invasion capacity in?vitro, and xenograft formation and growth in nude mice. NSCLC A549 cells treated with TGF-β were subjected to miRNA microarray analysis and miR?143 was selected for further study of tumor cell viability, wound healing, invasion capacity in?vitro, and tumor growth in nude mice. TGF-β treatment upregulated expression of 16 miRNAs and downregulated expression of 42 miRNAs in A549 cells. qRT-PCR and in?situ hybridization data showed that miR?143 was significantly downregulated in 24 NSCLC and lymph node metastatic tumor tissues, but upregulated by TGF-β treatment in A549 cells. In vitro experiments showed that miR?143 expression could significantly suppress NSCLC cell viability and invasion capacity, and nude mouse experiments confirmed the in?vitro data. Bioinformatic data predicted that Smad3, CD44 and K-Ras were the targeting genes of miR?143. TGF-β-induced miR?143 expression was associated with suppressed expression of Smad3, CD44, and K-Ras. This study sheds light on the role of TGF-β in upregulation of miR?143 and the role of miR?143 in NSCLC progression, indicating that the target of miR?143 expression could be further studied as a novel therapeutic strategy for future control of NSCLC.
机译:miRNA的表达改变有助于非小细胞肺癌(NSCLC)的发展和进展,而转化生长因子-β(TGF-β)则促进NSCLC细胞上皮-间质转化。这项研究旨在研究TGF-β诱导的miR?143表达对裸鼠NSCLC细胞活力,体外侵袭能力以及异种移植物形成和生长的调节作用。对经过TGF-β处理的NSCLC A549细胞进行miRNA微阵列分析,并选择miR?143进一步研究裸鼠的肿瘤细胞生存力,伤口愈合,体外侵袭能力和肿瘤生长。 TGF-β处理可上调A549细胞中16个miRNA的表达并下调42个miRNA的表达。 qRT-PCR和原位杂交数据显示,miR?143在24例NSCLC和淋巴结转移性肿瘤组织中显着下调,但在A549细胞中通过TGF-β处理上调。体外实验表明miR?143的表达可以显着抑制NSCLC细胞的活力和侵袭能力,裸鼠实验证实了其体外数据。生物信息学数据预测,Smad3,CD44和K-Ras是miR?143的靶向基因。 TGF-β诱导的miR?143表达与Smad3,CD44和K-Ras的表达受抑制有关。这项研究揭示了TGF-β在miR?143上调中的作用以及miR?143在NSCLC进展中的作用,表明miR?143表达的靶标可以作为进一步控制未来的新治疗策略进行研究。非小细胞肺癌。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号